In This Issue

Accreditation Statistics

As of October 1, 2023

Cellular Therapy Entities

  • Accredited: 258
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following programs for achieving initial FACT accreditation:

  • Kingston Health Sciences Centre
  • CTCA-COH Arizona Hematologic Malignancy and Cellular Therapy Institute (CAHCTI)
  • The Good Samaritan Hospital of Cincinnati, Ohio

A complete list of accredited organizations can be found at www.factglobal.org.

SITC Requests Feedback on Immune Effector Cell-Related Adverse Events Guideline

Posted in :: 2020 Volume 6 :: Monday, August 24th, 2020

Comments due by September 11, 2020

The Society for Immunotherapy of Cancer (SITC) announced a public comment period on its upcoming clinical practice guideline, The Society for Immunotherapy of Cancer consensus statement on immune effector cell-related adverse events. Comments are due by the end of September 11, 2020.

This manuscript is part of the SITC Cancer Immunotherapy Guidelines program, which is a collection of clinical practice guidelines available in the open-access, peer-reviewed online journal, Journal for ImmunoTherapy of Cancer (JITC). It was written by an expert panel that included representatives from the American Society of Hematology (ASH), the American Society for Transplantation and Cellular Therapy (ASTCT), and the Foundation for the Accreditation of Cellular Therapy (FACT).

Instructions for accessing the draft manuscript